“Drug use”的搜索结果，显示 71-80 项，共有 14754 项

1. 血液科- 临床试验- 妙佑医疗国际

   ... used followed by the target dose of ABBV-383. ... The Neuro-Oncology Program Registry and Biobank will be used ... This study is researching an experimental drug ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... used followed by the target dose of ABBV-383. ... The Neuro-Oncology Program Registry and Biobank will be used ... This study is researching an experimental drug ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   We will use information in the medical record in ... Jacksonville, Fla. This study is researching an experimental drug called ubamatamab, also referred to as " ...

4. 血液科- 临床试验- 妙佑医疗国际

   The drug combination of acalabrutinib, durvalumab, and venetoclax is ... However, the FDA has allowed the use of this drug in this research study.

5. 血液科- 临床试验- 妙佑医疗国际

   The drug combination of acalabrutinib, durvalumab, and venetoclax is ... However, the FDA has allowed the use of this drug in this research study.

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   However, the FDA has allowed the use of this drug in this research study. ... Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... use samples from the Biobank as well as share information already collected. ... However, the FDA has allowed the use of this drug in this research study.

8. 血液科- 临床试验- 妙佑医疗国际

   The drug combination of acalabrutinib, durvalumab, and venetoclax is ... However, the FDA has allowed the use of this drug in this research study.

9. 外科 - 临床试验- 妙佑医疗国际

   A Study Of Acute Stimulation For The Modulation Of Epileptic Events With A Closed-Loop Brain Interchange System In Drug Resistant Epilepsy ... use of new ...

10. 血液科- 临床试验- 妙佑医疗国际

    The drug combination of acalabrutinib, durvalumab, and venetoclax is ... However, the FDA has allowed the use of this drug in this research study.